4//SEC Filing
HOLMES EDWARD W 4
Accession 0001193805-23-001071
CIK 0001768224other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:11 PM ET
Size
8.5 KB
Accession
0001193805-23-001071
Insider Transaction Report
Form 4
HOLMES EDWARD W
Director
Transactions
- Award
Stock Option (right to buy)
2023-08-01+11,869→ 11,869 totalExercise: $34.92Exp: 2033-08-01→ Common Stock (11,869 underlying) - Award
Deferred Stock Units
2023-08-01+3,131→ 3,131 total→ Common Stock (3,131 underlying)
Footnotes (3)
- [F1]Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
- [F2]Each deferred stock unit is economically equivalent to one share of the Issuer's common stock
- [F3]Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
Documents
Issuer
Arcturus Therapeutics Holdings Inc.
CIK 0001768224
Entity typeother
Related Parties
1- filerCIK 0001197099
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:11 PM ET
- Size
- 8.5 KB